NSCLCIN75
TMB in NSCLC patients treated with combination immunotherapy
Tumor mutation burden estimated with whole exome sequencing of 43 NSCLC patient tumors treated with anti-PD-1 + anti-CTLA-4
Tumor mutation burden estimated with whole exome sequencing of 43 NSCLC patient tumors treated with anti-PD-1 + anti-CTLA-4